

Markel Group vs Huntington
Specialty insurer combining insurance and investment activities vs Regional bank offering commercial and consumer banking services. Which is the better buy for your portfolio in August 2026? Plain-English answer below.
Markel Group runs a specialty insurance operation and compounds capital like a mini-Berkshire, plowing underwriting profits into long-term equity investments, while Huntington Bancshares grows deposits and loans across the Midwest as a straightforward regional bank. Both firms are in the business of managing financial risk and allocating capital, but the tools they use couldn't be more different. Markel Group vs Huntington examines how each generates returns on equity and what investors are actually paying for when they buy either name.
Markel Group runs a specialty insurance operation and compounds capital like a mini-Berkshire, plowing underwriting profits into long-term equity investments, while Huntington Bancshares grows deposit...
Why It’s Moving

Markel stays under pressure as cautious analyst calls outweigh steady operating results.
- Analysts remain cautious on Markel after its early-August second-quarter update showed operating revenue holding flat year over year, reinforcing the view that growth is steady but not accelerating.
- Recent broker commentary has tilted defensive, with several firms maintaining Hold-equivalent ratings and one recent downgrade to Underperform, which has kept expectations subdued despite the company’s stable insurance footprint.
- Recent investor buying headlines, including large new positions from institutions, suggest some long-term confidence in Markel’s balance sheet and underwriting model, but they have not been enough to shift the broader cautious tone.

HBAN is drawing fresh support as analyst upgrades and steady bank fundamentals keep the upside story alive.
- Analyst sentiment has improved, with multiple firms reiterating or initiating favorable views on HBAN over the past week, helping reinforce the case for continued upside.
- Recent institutional buying disclosures have added a supportive tone, suggesting larger investors are still willing to add exposure even after the stock’s strong year-to-date run.
- HBAN’s latest quarterly results continued to show healthier net interest income, stronger fee income, and better operating momentum, which is keeping attention on the bank’s earnings power.

Markel stays under pressure as cautious analyst calls outweigh steady operating results.
- Analysts remain cautious on Markel after its early-August second-quarter update showed operating revenue holding flat year over year, reinforcing the view that growth is steady but not accelerating.
- Recent broker commentary has tilted defensive, with several firms maintaining Hold-equivalent ratings and one recent downgrade to Underperform, which has kept expectations subdued despite the company’s stable insurance footprint.
- Recent investor buying headlines, including large new positions from institutions, suggest some long-term confidence in Markel’s balance sheet and underwriting model, but they have not been enough to shift the broader cautious tone.

HBAN is drawing fresh support as analyst upgrades and steady bank fundamentals keep the upside story alive.
- Analyst sentiment has improved, with multiple firms reiterating or initiating favorable views on HBAN over the past week, helping reinforce the case for continued upside.
- Recent institutional buying disclosures have added a supportive tone, suggesting larger investors are still willing to add exposure even after the stock’s strong year-to-date run.
- HBAN’s latest quarterly results continued to show healthier net interest income, stronger fee income, and better operating momentum, which is keeping attention on the bank’s earnings power.
Investment Analysis

Markel Group
MKL
Pros
- Markel Group delivered strong earnings growth, with adjusted operating income up 24% year-on-year and revenue surpassing expectations.
- The company maintains a diversified business model across insurance, industrial, financial, and consumer segments, supporting resilience in mixed markets.
- Markel Group has consistently repurchased shares and invested in technology, enhancing shareholder value and operational efficiency.
Considerations
- The stock trades at a high forward price-to-earnings ratio, potentially reflecting elevated valuation relative to historical averages.
- Markel's insurance operations remain exposed to underwriting cycles and potential volatility in global markets.
- The company's international performance, while strong, could be sensitive to currency fluctuations and regulatory changes abroad.

Huntington
HBAN
Pros
- Huntington Bancshares reported robust earnings, with recent EPS significantly exceeding analyst forecasts and a stable dividend policy.
- The bank has increased its quarterly dividend, reflecting confidence in cash flow and capital strength.
- Huntington maintains a solid regional presence with a focus on commercial and retail banking, supporting steady loan growth.
Considerations
- Huntington's profitability is sensitive to interest rate changes, which could impact net interest margins in a shifting rate environment.
- The bank faces competitive pressures from larger national institutions and fintech disruptors in the retail banking sector.
- Regional banks like Huntington may be exposed to economic downturns affecting local markets and credit quality.
next-earnings-date-heading
The next earnings date for MKL is expected on November 4, 2026, based on its usual reporting pattern. This report should cover Q3 2026 results. Markel Group has not formally confirmed the date yet, so it remains an estimated schedule.
next-earnings-date-heading
The next earnings date for HBAN is expected on October 22, 2026, based on the company’s reported schedule and historical quarterly timing. This release will cover third-quarter 2026 financial results. Huntington Bancshares typically reports before the market opens on that date.
next-earnings-date-heading
The next earnings date for MKL is expected on November 4, 2026, based on its usual reporting pattern. This report should cover Q3 2026 results. Markel Group has not formally confirmed the date yet, so it remains an estimated schedule.
next-earnings-date-heading
The next earnings date for HBAN is expected on October 22, 2026, based on the company’s reported schedule and historical quarterly timing. This release will cover third-quarter 2026 financial results. Huntington Bancshares typically reports before the market opens on that date.
Buy MKL or HBAN in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


